Cancer Immunology Research
AACR's tumour immunology journal: mechanisms of immune response and escape, checkpoint and cell-therapy biology and immune biomarkers.
Cancer Immunology Research has appeared monthly since 2013 and publishes basic and translational tumour immunology, T-cell and myeloid biology in the microenvironment, neoantigen and vaccine research and correlative studies from immunotherapy trials. Hybrid access.
Pancreatic cancer immunologist who developed the GVAX vaccine and led national cancer policy panels.
Hatem Soliman is a breast oncologist leading immunotherapy and genomic-assay trials, including in triple-negative disease.
Developed the MANAFEST assay to track the tumour-specific T cells that immunotherapy awakens.
Pawel Kalinski is an immunologist reprogramming tumour microenvironments so T cells can enter.